No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Spotlight on T-Mobile US: Analyzing the Surge in Options Activity
Gilead Sciences Presented First Clinical Data For Its Investigational Once-Yearly Lenacapavir For HIV Prevention At CROI 2025 And Published In The Lancet
T-Mobile Shares Are Trading Lower in Sympathy With AT&T and Verizon, Which Fell on Their Respective Outlooks.
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
The Analyst Verdict: Gilead Sciences In The Eyes Of 14 Experts
Top 3 Health Care Stocks That May Keep You Up At Night In Q1